Jonathan Slonin, Chief Medical Officer at Pacira BioSciences, Inc. (PCRX), sold 10,024 shares at $28.57 ($286K) on 2024-06-11, disclosed to the SEC on 2024-06-13.
Scheduled sale ($286k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.57 | 5,012 | $143K | 50.0% |
| 2 | $28.57 | 5,012 | $143K | 50.0% |
| Total | $28.57 avg | 10,024 | $286K | 100% |
| Filing → |
| PCRX | SELL | 2025-11-19 | $191K | — | Filing → |
| PCRX | SELL | 2025-01-06 | $16K | — | Filing → |
| PCRX | SELL | 2024-08-02 | $19K | — | Filing → |